Your browser doesn't support javascript.
loading
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial.
Bockorny, Bruno; Semenisty, Valerya; Macarulla, Teresa; Borazanci, Erkut; Wolpin, Brian M; Stemmer, Salomon M; Golan, Talia; Geva, Ravit; Borad, Mitesh J; Pedersen, Katrina S; Park, Joon Oh; Ramirez, Robert A; Abad, David G; Feliu, Jaime; Muñoz, Andres; Ponz-Sarvise, Mariano; Peled, Amnon; Lustig, Tzipora M; Bohana-Kashtan, Osnat; Shaw, Stephen M; Sorani, Ella; Chaney, Marya; Kadosh, Shaul; Vainstein Haras, Abi; Von Hoff, Daniel D; Hidalgo, Manuel.
Afiliación
  • Bockorny B; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Semenisty V; Harvard Medical School, Boston, MA, USA.
  • Macarulla T; Oncology, Rambam Health Care Campus, Haifa, Israel.
  • Borazanci E; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, IOB Quirón, Barcelona, Spain.
  • Wolpin BM; HonorHealth Research Institute, Scottsdale, AZ, USA.
  • Stemmer SM; Translational Genomics Research Institute, Phoenix, AZ, USA.
  • Golan T; Harvard Medical School, Boston, MA, USA.
  • Geva R; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.
  • Borad MJ; Institute of Oncology, Davidoff Center, Rabin Medical Center, Petah Tikva, Israel.
  • Pedersen KS; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Park JO; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Ramirez RA; Oncology, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
  • Abad DG; Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Feliu J; Tel-Aviv University, Tel Aviv, Israel.
  • Muñoz A; Oncology, Mayo Clinic Cancer Center, Scottsdale, AZ, USA.
  • Ponz-Sarvise M; Oncology, Washington University School of Medicine, St. Louis, MO, USA.
  • Peled A; Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Lustig TM; Oncology, Ochsner Medical Center, New Orleans, LA, USA.
  • Bohana-Kashtan O; Grupo Oncologia Fuenlabrada, Madrid, Spain.
  • Shaw SM; Instituto de Investigación Hospital Universitario La Paz (IdIPAZ), Cátedra UAM-AMGEN, CIBERONC, Madrid, Spain.
  • Sorani E; Medical Oncology Service, Instituto de Investigación Sanitaria Hospital Gregorio Marañón, Universidad Complutense, Madrid, Spain.
  • Chaney M; Clinica Universidad de Navarra and Program in Solid Tumors (CIMA), Universidad de Navarra, IDISNA, Pamplona, Spain.
  • Kadosh S; Goldyne Savad Institute of Gene Therapy, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Vainstein Haras A; BioLineRx Ltd, Modi'in, Israel.
  • Von Hoff DD; BioLineRx Ltd, Modi'in, Israel.
  • Hidalgo M; BioLineRx Ltd, Modi'in, Israel.
Nat Med ; 26(6): 878-885, 2020 06.
Article en En | MEDLINE | ID: mdl-32451495

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Neoplasias Peritoneales / Neoplasias Retroperitoneales / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Ductal Pancreático / Neoplasias Hepáticas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Neoplasias Peritoneales / Neoplasias Retroperitoneales / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Ductal Pancreático / Neoplasias Hepáticas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos